Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Deep Kinsale Prospect Farm-In

21 Feb 2013 07:00

RNS Number : 3432Y
Fastnet Oil & Gas PLC
21 February 2013
 



21 February 2013

Fastnet Oil & Gas plc

("Fastnet" or the "Company")

 

FASTNET EXECUTES EXCLUSIVE OPTION AGREEMENT TO FARM INTO THE "DEEP KINSALE PROSPECT" BENEATH THE KINSALE HEAD GAS FIELD

 

Highlights

 

§ Exclusive option agreed with PSE Kinsale Energy Limited ("Kinsale Energy") to farm into the "Deep Kinsale Prospect" beneath the producing Kinsale Head gas field

 

§ Minimum of 500 sq. km. 3D seismic to be acquired in 2013

 

§ Potential to drill in 2014 to earn 60% working interest (reducing to a minimum of 40% should Kinsale Energy exercise certain back-in rights)

 

§ Deep Kinsale Prospect geologically similar to and on trend with Barryroe (Purbecko-Wealden reservoirs)

 

§ Strategy to build a material portfolio of Purbecko-Wealden prospective structures now complete - Deep Kinsale, Mizzen, Shanagarry and 49/13

 

Fastnet (AIM: FAST, ESM: FOI) the listed E&P company focused on near term exploration acreage in the Celtic Sea and Morocco, is pleased to announce  that it has executed an exclusive option agreement (the "Agreement") with Kinsale Energy, a wholly owned subsidiary of PETRONAS, to farm into the "Deep Kinsale Prospect" from 4,000 feet subsea below the producing Kinsale Head gas field defined by a sub-area (the "Deep Kinsale Sub-Area) of Petroleum Lease No. 1 (see map of the area on the Company's website: www.fastnetoilandgas.com/go/operations/ireland).

 

The key terms of the Agreement are as follows:

 

·; Deep Kinsale Sub-Area covers parts of Blocks 48/20, 48/25, 49/16 and 49/21;

·; Exclusive option confined to geological formations below 4,000 feet subsea;

·; Fastnet to acquire a minimum of 500 sq. km. of 3D seismic by 31 December 2013 and to complete geological and engineering studies;

·; Fastnet to have an exclusive option to farm in, exercisable before 30 September 2014, by commencing a well ("Farm-in Well") on or before 30 November 2015 to test the Purbecko-Wealden reservoirs, productive in Barryroe;

·; The Farm-in Well to be drilled to a provisional depth of 8,000 feet subsea;

·; Upon completion and, if warranted, testing of the Farm-in Well Fastnet will earn a 60% working interest in the Deep Kinsale Sub-Area by funding 100% of all drilling and testing costs;

·; Kinsale Energy shall have the back-in option, exercisable at its discretion within a period of 30 Business Days of completion by Fastnet of the exercise of the Option, to increase its interest in the Kinsale Deep Sub-Area by 10%, by paying for 16.667% of the drilling and testing costs of the Farmin Well; and

·;  If there is a commercial development, Kinsale Energy shall have the option to increase its working interest for no consideration, by 5% once production exceeds 100 million barrels oil equivalent ("MMBOE"), by a further 5% once production exceeds 150 MMBOE oil equivalent and by a further 5% once production exceeds 200 MMBOE subject to the Kinsale Energy's working interest not exceeding 60% in aggregate.

 

The assignment of working interest in the Deep Kinsale Sub-Area following completion of the Farmin Well is subject to the consent of the Minister for Communications, Energy and Natural Resources.

 

About the Deep Kinsale Prospect

 

In 1970 Marathon Petroleum Company (Ireland) Ltd drilled the 48/25-1 well at Kinsale Head, the first well in the North Celtic Sea Basin. Subsequently in 1972 the 48/25-2 and 48/20-1a wells were drilled to appraise the Kinsale Head structure updip from 48/25-1 at the shallow Greensand reservoir level. This led to the discovery of the Kinsale Head gas field, which came on stream in 1978.

 

Recent studies by Fastnet in the Mizzen and Shanagarry Licensing Options have provided the Board with a better regional understanding of the structural and stratigraphic controls governing the distribution of the Purbecko-Wealden oil-bearing reservoir sequences which have allowed Fastnet to develop a regional play concept.

 

Fastnet intend to acquire a minimum of 500 sq. km. of 3D seismic over the Kinsale Head area in the first half of 2013 and has selected CGG as its preferred seismic contractor for 3D seismic acquisition in the Celtic Sea, as announced on 18th February 2013. This will be the first 3D survey over Kinsale Head to target the deeper oil and gas potential of the Kinsale Head structure. The intention is to de-risk the deep structure through potentially better seismic imaging of both the structure and potential variations in reservoir thickness and quality.

 

Cathal Friel, Chairman of Fastnet said:

 

"We are delighted to have added an exclusive option to farm into and potentially drill the Deep Kinsale Prospect in 2014. It represents an attractive addition to our Irish portfolio as we have long held a belief that Deep Kinsale offers the potential to yield up another significant hydrocarbon discovery offshore Ireland. This belief has been further strengthened by the successful appraisal of Barryroe in 2012, which is geologically analogous to Deep Kinsale. We greatly look forward to working in close cooperation with our colleagues at Kinsale Energy, as we collectively seek to de-risk the prospect for drilling."

 

For further information please contact:

 

Fastnet Oil & Gas plc

Cathal Friel, Chairman

Paul Griffiths, Managing Director

+353 (1) 644 0007

Shore Capital

Nomad

Bidhi Bhoma, Edward Mansfield

 

Corporate Broking

Jerry Keen

+44 (0) 20 7408 4090

 

Mirabaud Securities LLP

(Joint Broker)

Peter Krens, Edward Haig-Thomas

 

 

 

+44 (20) 7321 2508

 

Davy

(ESM Adviser & Joint Broker)

John Frain, Anthony Farrell

 

+353 (1) 679 6363

FTI Consulting

Edward Westropp, Natalia Erikssen, Jess Allum

+44 (0) 207 831 3113

 

 

Notes to editors

 

Fastnet Oil & Gas plc is an independent oil and gas exploration company that focuses on identifying early stage exploration and appraisal opportunities in Offshore Ireland and Africa. It is quoted on the AIM market of the London Stock Exchange and the Enterprise Securities Market (ESM) of the Irish Stock Exchange. Fastnet's aim is to assemble a portfolio of high impact conventional oil and gas assets that will deliver sustainable growth and value for the Company. Its immediate focus is on implementing its Offshore Ireland and Africa strategies where it has been awarded four offshore licensing options in the Celtic Sea (Molly Malone Basin, Shanagarry, 49/13 and Mizzen Basin) and acquired a material interest in the highly prospective Foum Assaka permit Offshore Morocco. In addition, Fastnet will continue to pursue new conventional oil and gas opportunities in Africa where the Directors and Advisory Board also have extensive knowledge, contacts and experience of creating value.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRGDDCXDBGXG
Date   Source Headline
6th Jan 20225:30 pmRNSAmryt Pharma
6th Jan 20227:00 amGNWKey Dates for AIM Delisting
4th Jan 202212:00 pmGNWThe Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa® (oral octreotide) in Acromegaly Patients
4th Jan 20227:00 amGNWTotal Voting Rights
1st Dec 20217:00 amGNWTotal Voting Rights
30th Nov 20217:00 amGNWDirector/PDMR Shareholding
23rd Nov 202112:00 pmGNWAmryt Provides Update on Regulatory Review Process for Oleogel-S10
22nd Nov 20217:00 amGNWAmryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
3rd Nov 202111:00 amGNWAmryt Reports Strong Q3 2021 Results
1st Nov 20211:00 pmGNWTotal Voting Rights
1st Nov 20217:00 amRNSAmryt Supports Acromegaly Awareness Day
22nd Oct 20217:00 amRNSAmryt Supports Global EB Awareness Week 2021
20th Oct 202112:00 pmGNWAmryt to Report Q3 2021 Results and Host Conference Call & Webcast on November 3
19th Oct 202112:00 pmGNWAmryt Announces New Patents for Oleogel-S10 and Mycapssa®
23rd Sep 202112:00 pmRNSAmryt Supports Global FH Awareness Day
13th Sep 202112:00 pmGNWAmryt Raises Full Year 2021 Revenue Guidance to $220M - $225M
1st Sep 20217:00 amGNWTotal Voting Rights
19th Aug 20217:00 amGNWAmryt Issues Ordinary Shares and Total Voting Rights
13th Aug 20211:23 pmRNSHolding(s) in Company - Replacement
11th Aug 202111:30 amRNSHoldings in Company
11th Aug 202110:36 amRNSHolding(s) in Company
10th Aug 20212:20 pmGNWDirector/PDMR Shareholding
10th Aug 20219:53 amRNSHolding(s) in Company
9th Aug 202112:00 pmGNWAmryt Virtual Capital Markets Event - September 13, 2021 – 1000-1200 EDT
6th Aug 202112:00 pmGNWAmryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
5th Aug 20213:50 pmGNWAmryt Successfully Completes Acquisition of Chiasma, Inc., Board Appointments, Issues Ordinary Shares and Total Voting Rights
28th Jul 20213:00 pmGNWResult of General Meetings
12th Jul 202112:00 pmGNWAmryt to Report Q2 2021 Results and Host Conference Call & Webcast on August 6
28th Jun 202112:00 pmGNWPublication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings
15th Jun 202111:45 amGNWAmryt Pharma Announces Filing of Preliminary Registration Statement on Form F-4 in Connection with Its Proposed Acquisition of Chiasma, Inc.
7th Jun 202112:00 pmGNWFDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
3rd Jun 20217:00 amGNWFDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
2nd Jun 20211:30 pmGNWAmryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
5th May 20214:41 pmRNSSecond Price Monitoring Extn
5th May 20214:35 pmRNSPrice Monitoring Extension
5th May 202112:05 pmGNWAmryt Reports Record Q1 2021 Financial and Operating Results
5th May 202112:00 pmGNWAmryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
15th Apr 202112:00 pmGNWAmryt to Report Q1 2021 Results and Host Conference Call & Webcast on May 5
6th Apr 20217:00 amGNWAmryt Announces the Appointment of Sheila Frame as President Americas
31st Mar 202111:00 amRNSAmryt Supports World Lipodystrophy Day
31st Mar 20217:00 amGNWAmryt Submits a New Drug Application to the US Food and Drug Administration for Oleogel-S10* (Filsuvez®)
30th Mar 20217:00 amGNWAmryt Announces Results from an Investigator Sponsored Study of Lomitapide in FCS
29th Mar 20217:00 amGNWAmryt Announces Validation of its MAA by the EMA for Oleogel-S10* (Filsuvez®)
23rd Mar 20217:00 amGNWAmryt Receives Positive Feedback from the FDA on the Path Forward for Myalept® (metreleptin) Indication in Partial Lipodystrophy
22nd Mar 20217:00 amGNWAmryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta® (metreleptin)
15th Mar 202110:00 amGNWDirector/PDMR Shareholding
12th Mar 20217:00 amGNWExercise of Options and Total Voting Rights
11th Mar 202111:30 amGNWExercise of Warrants & Issue of Ordinary Shares and Total Voting Rights
8th Mar 20216:00 pmGNWDirector/PDMR Shareholding
8th Mar 20217:00 amGNWAmryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.